Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Contents:; Skin cancer / Central nervous system / Malignant and benign diseases of the eye and orbit / Cancer of the ear / Nasopharyngeal cancer / Nasal cavity and paranasal sinus cancer / Oropharyngeal cancer / Cancer of the lip an oral cavity / Larynx and Hypopharynx cancer / Salivary gland tumor…
c.1 BC Cancer Agency KEL Library | Available |
The majority of the articles from the May 2013 CHEST Supplement "Lung cancer guidelines" are online only. The individual chapters are only available as electronic files. The print edition only includes the following articles which are free online to view: Disclaimer; Panel List; Executive Summary…
Table of Contents:; 1. Radiation Dermatitis -- 2. Hair Loss -- 3. Radiation Brain Injury -- 4. Radiation Orbital Toxicity -- 5. Ear Toxicity -- 6. Oral Mucositis -- 7. Xerostomia -- 8. Loss of Taste -- 9. Laryngeal Edema -- 10. Radiation Pneumonitis -- 11. Pericarditis -- 12. Esophagitis -- 13. Ra…
c.1 BC Cancer Agency KEL Library | Available |
v.1: Sources : report of the United Nations Scientific Committee on the effects of atomic radiation to the General Assembly; Scientifc Annexes: Annex A: Medical radiation exposures; Annex B: Exposures of the public and workers from various sources of radiation
c.1 BC Cancer Agency VAN Library | Available |
Contents:; Why read papers at all? -- Searching the literature -- Getting your bearings : what is this paper about? -- Assessing methodological quality -- Statistics for the non-statistician -- Papers that report trials of drugs and other simple interventions -- Papers that report trials of complex…
c.1 BC Cancer Agency VIC Library Missing | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
PART I: INTRODUCTION AND BACKGROUND; 1 INTRODUCTION; 2 CANNABIS; 3 CANNABIS: PREVALENCE OF USE, REGULATION, AND CURRENT POLICY LANDSCAPE; PART II: THERAPEUTIC EFFECTS; 4 THERAPEUTIC EFFECTS OF CANNABIS AND CANNABINOIDS; PART III: OTHER HEALTH EFFECTS; 5 CANCER; 7 RESPIRATORY DISEASE; 8 IMMUNITY; 9…
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library Missing | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 June, 2009.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Contents:; The Current Cancer Care Landscape: An Imperative for Change -- Patient-Centered Communication and Shared Decision Making -- The Workforce Caring for Patients with Cancer -- The Evidence Base for High-Quality Cancer Care -- A Learning Health Care Information Technology System for Cancer -…
c.1 BC Cancer Agency VIC Library | Available |
This publication represents the views and expert opinions of an IARC working group on the evaluation of carcinogenic risks to humans, which met in Lyon, 24-31 May 2011